Lantern Pharma is trading at $1.18, up 8.26% after hours versus its September 28 regular-session close of $1.09, with no clear company-specific catalyst identified.
- Lantern Pharma’s investor-relations page lists no September 28 release; its latest listed announcement is dated September 17.
- Major indexes fell during the session, which does not clearly explain the opposite-direction after-hours move. The September 22 patent notice is earlier news, not a confirmed catalyst.